Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pertussis in adults: frequency of transmission after household exposure.
Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Wirsing von König CH, et al. Among authors: bock hl. Lancet. 1995 Nov 18;346(8986):1326-9. doi: 10.1016/s0140-6736(95)92343-8. Lancet. 1995. PMID: 7475771
Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH, Tan PT, Han HH, Bock HL. Chan SH, et al. Among authors: bock hl. Singapore Med J. 2006 Apr;47(4):286-90. Singapore Med J. 2006. PMID: 16572239
Symptoms and complications of pertussis in adults.
Postels-Multani S, Schmitt HJ, Wirsing von König CH, Bock HL, Bogaerts H. Postels-Multani S, et al. Among authors: bock hl. Infection. 1995 May-Jun;23(3):139-42. doi: 10.1007/BF01793853. Infection. 1995. PMID: 7499001
Immunogenicity of a recombinant hepatitis B vaccine in adults.
Bock HL, Kruppenbacher J, Sänger R, Höbel W, Clemens R, Jilg W. Bock HL, et al. Arch Intern Med. 1996 Oct 28;156(19):2226-31. Arch Intern Med. 1996. PMID: 8885822
Factors influencing the spread of pertussis in households.
Wirsing von König CH, Postels-Multani S, Bogaerts H, Bock HL, Laukamp S, Kiederle S, Schmitt HJ. Wirsing von König CH, et al. Among authors: bock hl. Eur J Pediatr. 1998 May;157(5):391-4. doi: 10.1007/s004310050836. Eur J Pediatr. 1998. PMID: 9625336
Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies.
Weigl JA, Bock HL, Clemens R, Zepp F, Habermehl P, Beutel K, Müschenborn S, Sümenicht G, Schuind A, von König CH, Neiss A, Laukamp S, Kiederle S, Schmitt HJ. Weigl JA, et al. Among authors: bock hl. Ann Acad Med Singap. 1997 May;26(3):320-5. Ann Acad Med Singap. 1997. PMID: 9285026 Review.
Factors influencing the analysis of secondary prevention of pertussis.
Wirsing von König CH, Schmitt HJ, Bogaerts H, Bock HL, Laukamp S, Kiederle S, Postels-Multani S. Wirsing von König CH, et al. Among authors: bock hl. Dev Biol Stand. 1997;89:175-9. Dev Biol Stand. 1997. PMID: 9272349 Clinical Trial.
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age.
Schmitt HJ, Beutel K, Schuind A, Knuf M, Wagner S, Müschenborn S, Bogaerts H, Bock HL, Clemens R. Schmitt HJ, et al. Among authors: bock hl. J Pediatr. 1997 Apr;130(4):616-23. doi: 10.1016/s0022-3476(97)70247-6. J Pediatr. 1997. PMID: 9108861 Clinical Trial.
Acellular pertussis vaccines: the rationale for an efficacy trial in Germany.
Schmitt HJ, Schuind A, Knuf M, Zepp F, Beutel K, Wirsing von König CH, Neiss A, Bock HL, Bogaerts H, Clemens R. Schmitt HJ, et al. Among authors: bock hl. J Infect Dis. 1996 Nov;174 Suppl 3:S287-90. doi: 10.1093/infdis/174.supplement_3.s287. J Infect Dis. 1996. PMID: 8896531 Review.
Efficacy of acellular pertussis vaccine in early childhood after household exposure.
Schmitt HJ, von König CH, Neiss A, Bogaerts H, Bock HL, Schulte-Wissermann H, Gahr M, Schult R, Folkens JU, Rauh W, Clemens R. Schmitt HJ, et al. Among authors: bock hl. JAMA. 1996 Jan 3;275(1):37-41. JAMA. 1996. PMID: 8531284
127 results
Jump to page
Feedback